Approval · Notice of Compliance 5651 · 2004
KIDROLASE: Notice of Compliance 5651
Issued October 18, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5651
- Date
- October 18, 2004
- Company
- Opi S.A.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antileukemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KIDROLASE | 01926438 | Cancelled Post Market |
Medicinal ingredients
- ASPARAGINASE 10,000 UNIT per VIAL